ResearcherRush University Medical CenterActive in the last 2 years
Sam G. Pappas
Matched on ORCID iD 0000-0003-1697-8268; OpenAlex author ID A5047639268. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 6
- Looking Beyond Checkpoint Inhibitor Monotherapy: Uncovering New Frontiers for Pancreatic Cancer Immunotherapy. Co-author DOI 10.1158/1535-7163.mct-24-0311↗
- Tetanus Toxoid Utilizes Dual-Faceted Anticancer Mechanism Through Targeting Tumoral Sialic Acids and Enhancing Cytotoxic CD4+ T cell Responses Against Pancreat… First author DOI 10.1101/2024.11.19.624337↗
- Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer. Co-author DOI 10.3390/ijms21207651↗
- Diagnostic laparoscopy should be performed before definitive resection for pancreatic cancer: a financial argument. Co-author DOI 10.1111/hpb.12325↗
- Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility or futility? Co-author DOI 10.1111/hpb.12074↗
- Borderline resectable/locally advanced pancreatic adenocarcinoma: improvements needed in population-based registries. Co-author DOI 10.1245/s10434-013-3237-6↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kajal H. Gupta · 2 shared papers, 2024–2025 · strength 0.73
- Paper Looking Beyond Checkpoint Inhibitor Monotherapy: Uncovering New Frontiers for Pancreatic Cancer Immunotherapy. DOI 10.1158/1535-7163.mct-24-0311↗
- Paper Tetanus Toxoid Utilizes Dual-Faceted Anticancer Mechanism Through Targeting Tumoral Sialic Acids and Enhancing Cytotoxi… DOI 10.1101/2024.11.19.624337↗
- Eileena F. Giurini · 2 shared papers, 2024–2025 · strength 0.73
- Paper Looking Beyond Checkpoint Inhibitor Monotherapy: Uncovering New Frontiers for Pancreatic Cancer Immunotherapy. DOI 10.1158/1535-7163.mct-24-0311↗
- Paper Tetanus Toxoid Utilizes Dual-Faceted Anticancer Mechanism Through Targeting Tumoral Sialic Acids and Enhancing Cytotoxi… DOI 10.1101/2024.11.19.624337↗
- Ashiq Masood · 1 shared paper, 2020 · strength 0.15
- Miles W. Grunvald · 1 shared paper, 2020 · strength 0.15
- Kiran Kalyan Turaga · 3 shared papers, 2013–2015 · strength 0.13
- Paper Borderline resectable/locally advanced pancreatic adenocarcinoma: improvements needed in population-based registries. DOI 10.1245/s10434-013-3237-6↗
- Paper Diagnostic laparoscopy should be performed before definitive resection for pancreatic cancer: a financial argument. DOI 10.1111/hpb.12325↗
- Paper Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility … DOI 10.1111/hpb.12074↗
- Douglas B. Evans · 3 shared papers, 2013–2015 · strength 0.13
- Paper Borderline resectable/locally advanced pancreatic adenocarcinoma: improvements needed in population-based registries. DOI 10.1245/s10434-013-3237-6↗
- Paper Diagnostic laparoscopy should be performed before definitive resection for pancreatic cancer: a financial argument. DOI 10.1111/hpb.12325↗
- Paper Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility … DOI 10.1111/hpb.12074↗
- Paul S. Ritch · 2 shared papers, 2014–2015 · strength 0.08
- Susan Tsai · 2 shared papers, 2014–2015 · strength 0.08
- Kathleen K. Christians · 2 shared papers, 2014–2015 · strength 0.08
- John Thomas Miura · 1 shared paper, 2013 · strength 0.05
- Thejus Jayakrishnan · 1 shared paper, 2015 · strength 0.05
- Ben George · 1 shared paper, 2015 · strength 0.05
- Bradley A. Erickson · 1 shared paper, 2014 · strength 0.04
- Parag P. Tolat · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.